Abstract
Purpose: The goal of this study was to identify a disease modifying osteoarthritis drug (DMOAD) that regenerates healthy hyaline cartilage in osteoarthritis (OA) through differentiation of endogenous mesenchymal stem cells (MSCs) into chondrocytes and the production of healthy hyaline cartilage matrix. Using a phenotypic screen, we discovered LNA043, a derivative of the angiopoietin-like 3 (ANGPTL3) protein and confirmed that it promotes chondrogenesis in vitro and cartilage regeneration in vivo.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
